SatorIs Vision & GOALS

Enabling the right treatment for the right patient, at the right time.

Our goal: best and earliest

At Satoris, our commitment goes beyond merely developing tests for neurological diseases such as Alzheimer’s, Parkinson’s, Multiple Sclerosis, and Diabetic Neuropathy. We’re committed to developing and commercializing neurodiagnostic tests that yield the earliest, most accurate, and most clinically relevant diagnoses, so that healthcare costs can be reduced while patient care becomes even more effective.

How are we helping?

In the last decade, tremendous advances have been made in exploring and mapping the human genome and proteome. The current biotechnology challenge is to make practical use of the knowledge gained. Satoris uses a unique approach to the identification and characterization of protein biomarkers associated with neurological disease to create new diagnostic tools for earlier, better healthcare decisions.

Who are we helping?

• Patients: Our tests minimize the time between disease onset and treatment initiation. The tests are also highly specific, so better treatment choices can be made.
• Partners: We provide biomarker testing and analysis to our partners, leading pharmaceutical companies, who use this information in the development of more effective therapies.
• Clinicians: We enable neurological diseases to be identified earlier and with greater accuracy.
• Payors: We help bring efficiency to neurological healthcare — with cost-effective tests that provide critical information for treatment decisions.